Aim: This study aimed to evaluate the efficacy of the resin hemoperfusion device (HA380 hemoperfusion cartridge) on inflammatory responses during adult cardiopulmonary bypass (CPB). Methods: Sixty patients undergoing surgical valve replacement were randomized into the HP group (n = 30) with an HA380 hemoperfusion cartridge in the CPB circuit or the control group (n = 30) with the conventional CPB circuit. The results of routine blood tests, blood biochemical indexes, and inflammatory factors were analyzed at V0 (pre-CPB), V1 (CPB 30 min), V2 (ICU 0 h), V3 (ICU 6 h), and V4 (ICU 24 h). Results: The HP group had significantly lower levels of IL-6, IL-8, and IL-10. Significant estimation of group differences in the generalized estimating equation (GEE) models was also observed in IL-6 and IL-10. The HP group had significantly lower levels of creatinine (Cr), aminotransferase (AST), and total bilirubin (TBil) compared to the control group. The estimation of differences of Cr, AST, and TBil all reached statistical significance in GEE results. The HP group had significantly less vasopressor requirement and shorter mechanical ventilation time and ICU stay time as compared to the control group. Conclusion: The HA380 hemoperfusion cartridge could effectively reduce the systemic inflammatory responses and improve postoperative recovery of patients during adult CPB.

1.
Sarkar
M
,
Prabhu
V
.
Basics of cardiopulmonary bypass
.
Indian J Anaesth
.
2017 Sep
;
61
(
9
):
760
7
. .
2.
Ismail
A
,
Miskolczi
SY
.
Cardiopulmonary bypass
.
Treasure Island, FL
:
StatPearls Publishing
.
2020
.
3.
Clive Landis
R
,
Brown
JR
,
Fitzgerald
D
,
Likosky
DS
,
Shore-Lesserson
L
,
Baker
RA
,
Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: a critical review of the evidence base
.
J Extra Corpor Technol
.
2014
;
46
(
3
):
197
211
.
4.
Al-Fares
A
,
Pettenuzzo
T
,
Del Sorbo
L
.
Extracorporeal life support and systemic inflammation
.
Intensive Care Med Exp
.
2019
;
7
(
S1
):
46
. .
5.
Giacinto
O
,
Satriano
U
,
Nenna
A
,
Spadaccio
C
,
Lusini
M
,
Mastroianni
C
,
Inflammatory response and endothelial dysfunction following cardiopulmonary bypass: pathophysiology and pharmacological targets
.
Recent Pat Inflamm Allergy Drug Discov
.
2019 Dec
;
13
(
2
):
158
73
. .
6.
Haase-Fielitz
A
,
Haase
M
,
Bellomo
R
,
Calzavacca
P
,
Spura
A
,
Baraki
H
,
Perioperative hemodynamic instability and fluid overload are associated with increasing acute kidney injury severity and worse outcome after cardiac surgery
.
Blood Purif
.
2017
;
43
(
4
):
298
308
. .
7.
Höfer
J
,
Fries
D
,
Solomon
C
,
Velik-Salchner
C
,
Ausserer
J
.
A snapshot of coagulopathy after cardiopulmonary bypass
.
Clin Appl Thromb Hemost
.
2016 Sep
;
22
(
6
):
505
11
. .
8.
Greenwood
JC
,
Jang
DH
,
Hallisey
SD
,
Gutsche
JT
,
Horak
J
,
Acker
MA
,
Severe impairment of microcirculatory perfused vessel density is associated with postoperative lactate and acute organ injury after cardiac surgery
.
J Cardiothorac Vasc Anesth
.
2021
;
35
(
1
):
106
15
.
9.
Liu
CH
,
Kuo
SW
,
Hsu
LM
,
Huang
SC
,
Wang
CH
,
Tsai
PR
,
Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach
.
J Transl Med
.
2016
;
14
(
1
):
114
. .
10.
Burrell
AJC
,
Lubnow
M
,
Enger
TB
,
Nanjayya
VB
,
Philipp
A
,
Malfertheiner
MV
,
The impact of venovenous extracorporeal membrane oxygenation on cytokine levels in patients with severe acute respiratory distress syndrome: a prospective, observational study
.
Crit Care Resusc
.
2017
;
19
:
37
44
.
11.
Zhang
WR
,
Garg
AX
,
Coca
SG
,
Devereaux
PJ
,
Eikelboom
J
,
Kavsak
P
,
Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery
.
J Am Soc Nephrol
.
2015
;
26
(
12
):
3123
32
. .
12.
Baumann
A
,
Buchwald
D
,
Annecke
T
,
Hellmich
M
,
Zahn
PK
,
Hohn
A
.
RECCAS: Removal of cytokines during Cardiac surgery: study protocol for a andomized controlled trial
.
Trials
.
2016 Mar
;
17
(
1
):
137
.
13.
Evora
PRB
,
Bottura
C
,
Arcêncio
L
,
Albuquerque
AAS
,
Évora
PM
,
Rodrigues
AJ
.
Key points for curbing cardiopulmonary bypass inflammation
.
Acta Cir Bras
.
2016
;
31
(
Suppl 1
):
45
52
. .
14.
Pomarè Montin
D
,
Ankawi
G
,
Lorenzin
A
,
Neri
M
,
Caprara
C
,
Ronco
C
.
Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion
.
Blood Purif
.
2018
;
46
(
3
):
187
95
. .
15.
Huang
Z
,
Wang
SR
,
Yang
ZL
,
Liu
JY
.
Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column
.
Ther Apher Dial
.
2013
;
17
(
4
):
454
61
. .
16.
Wang
YT
,
Fu
JJ
,
Li
XL
,
Li
YR
,
Li
CF
,
Zhou
CY
.
Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome
.
Eur Rev Med Pharmacol Sci
.
2016
;
20
(
4
):
745
50
.
17.
Sun
S
,
He
L
,
Bai
M
,
Liu
H
,
Li
Y
,
Li
L
,
High-volume hemofltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study
.
Ann Saudi Med
.
2015
;
35
(
5
):
352
8
.
18.
Huang
Z
,
Wang
SR
,
Su
W
,
Liu
JY
.
Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column
.
Ther Apher Dial
.
2010
;
14
(
6
):
596
602
. .
19.
Dastan
F
,
Saffaei
A
,
Mortazavi
SM
,
Jamaati
H
,
Adnani
N
,
Samiee Roudi
S
,
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19
.
J Glob Antimicrob Resist
.
2020 Apr
;
21
:
340
1
. .
20.
Nemeth
E
,
Kovacs
E
,
Racz
K
,
Soltesz
A
,
Szigeti
S
,
Kiss
N
,
Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study
.
Clin Transplant
.
2018
;
32
(
4
):
e13211
. .
21.
Träger
K
,
Skrabal
C
,
Fischer
G
,
Datzmann
T
,
Schroeder
J
,
Fritzler
D
,
Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass: a case series
.
Int J Artif Organs
.
2017
;
40
(
5
):
240
9
. .
22.
Träger
K
,
Fritzler
D
,
Fischer
G
,
Schröder
J
,
Skrabal
C
,
Liebold
A
,
Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series
.
Int J Artif Organs
.
2016
;
39
(
3
):
141
6
. .
23.
Bernardi
MH
,
Rinoesl
H
,
Dragosits
K
,
Ristl
R
,
Hoffelner
F
,
Opfermann
P
,
Effect of hemoadsorption during cardiopulmonary bypass surgery: a blinded, randomized, controlled pilot study using a novel adsorbent
.
Crit Care
.
2016
;
20
(
1
):
96
. .
24.
Poli
EC
,
Alberio
L
,
Bauer-Doerries
A
,
Marcucci
C
,
Roumy
A
,
Kirsch
M
,
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
.
Crit Care
.
2019
;
23
(
1
):
108
.
25.
Clark
WR
,
Ferrari
F
,
La Manna
G
,
Ronco
C
.
Extracorporeal sorbent technologies: basic concepts and clinical application
.
Contrib Nephrol
.
2017
;
190
:
43
57
. .
26.
Hu
X
,
Gao
H
,
Liao
M
,
He
M
.
[The use of ha330-ii microporous resin plasma adsorption in the treatment of chronic severe hepatitis]
.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue
.
2007
;
19
:
760
1
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.